Two Sigma Advisers’s Crescent Biopharma CBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $385K | Buy |
|
|||||
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $42.1K | Buy |
|
|||||
|
2024
Q2 | $30.6K | Buy |
|
|||||
|
2024
Q1 | $87.9K | Sell |
|
|||||
|
2023
Q4 | $390K | Sell |
|
|||||
|
2023
Q3 | $329K | Sell |
|
|||||
|
2023
Q2 | $785K | Sell |
|
|||||
|
2023
Q1 | $749K | Buy |
|
|||||
|
2022
Q4 | $581K | Sell |
|
|||||
|
2022
Q3 | $114K | Sell |
|
|||||
|
2022
Q2 | $190K | Sell |
|
|||||
|
2022
Q1 | $443K | Sell |
|
|||||
|
2021
Q4 | $943K | Buy |
|
|||||
|
2021
Q3 | $1.36M | Sell |
|
|||||
|
2021
Q2 | $1.65M | Sell |
|
|||||
|
2021
Q1 | $2.66M | Buy |
|
|||||
|
2020
Q4 | $2.96M | Buy |
|
|||||
|
2020
Q3 | $999K | Buy |
|
|||||
|
2020
Q2 | $1.2M | Buy |
|
|||||
|
2020
Q1 | $464K | Buy |
|
|||||
|
2019
Q4 | $278K | Buy |
|